Dexmedetomidine modulates mitochondrial dynamics to protect against endotoxin-induced lung injury via the protein kinase C-ɑ/haem oxygenase-1 signalling pathway.
Kai SongJia ShiLina ZhanQiaoying GaoJing YangShuan DongYuan ZhangJian-Bo YuPublished in: Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals (2022)
Dexmedetomidine may activate the PKC-ɑ/HO-1 pathway to increase the expression of Mfn1, Mfn2, and OPA1, while decreasing Drp1 and Fis1 expression, thereby reduce endotoxin-induced acute lung injury.